The global Collagen Peptides Market was valued at USD 702.3 million in 2023 and is projected to grow from USD 738.6 million in 2024 to USD 1,103.6 million by 2031, exhibiting a compound annual growth rate (CAGR) of 5.91% during the forecast period, according to Kings Research. The market includes bioactive protein fragments derived from the enzymatic hydrolysis of collagen sourced from bovine, porcine, marine or poultry origins, designed for enhanced bioavailability and absorption.
Market Overview
Collagen peptides are used in nutraceuticals, functional foods, sports nutrition and personal care products, where they support skin health, joint function and muscle recovery. Growth is driven by the expanding global nutraceutical industry, as consumers seek natural and effective wellness solutions, and by the clean-label movement, which favors transparent, high-quality and safe ingredients.
Consumers are shifting toward health-oriented diets, and manufacturers are incorporating collagen peptides into functional food and beverage formulations. The preference for natural, protein-enriched ingredients has made collagen peptides a core component of health supplements and fortified food categories. In May 2024, GELITA unveiled OPTIBAR, a collagen peptide solution optimized for bar production that allows high-protein bars to have a soft texture and acts as a sugar-free binder, enabling “low sugar” and “no sugar” claims.
Key Highlights from the Report
- The market was valued at USD 702.3 million in 2023 and is projected to grow at a 5.91% CAGR from 2024 to 2031.
- North America held a 34.09% share in 2023, valued at USD 239.4 million.
- The bovine segment generated USD 295.7 million in revenue in 2023.
- The powder segment is expected to reach USD 838.7 million by 2031.
- Enzymatic hydrolysis secured the largest extraction share, at 63.02% in 2023.
- The cosmeceuticals segment is poised to grow at a CAGR of 8.14%.
- Asia Pacific is anticipated to grow at a CAGR of 6.70%, reaching USD 260.4 million in 2031.
Market Driver: Expanding Nutraceutical Industry
Collagen peptides are increasingly used in dietary supplements aimed at bone strength, skin elasticity and gut health. A rising geriatric population and greater awareness of preventive healthcare are encouraging manufacturers to invest in collagen-based formulations, accelerating adoption across capsule, powder and liquid formats. In February 2024, Evonik introduced Vecollage Fortify L, a vegan collagen ingredient identical to human skin collagen, developed through fermentation technology. It addresses rising demand for sustainable and ethical collagen sources in beauty and personal care, helping prevent age-related collagen degradation and stimulating the skin’s own collagen production.
Market Challenge: Sourcing and Sustainability
Rising demand for animal-derived collagen from bovine, marine and poultry sources puts pressure on supply chains and raises environmental concerns. Key players are investing in sustainable sourcing, exploring plant-based and lab-grown alternatives, adopting stricter traceability measures and using eco-friendly processing to reduce their footprint and meet consumer expectations for ethically sourced products.
Market Trend: Clean-Label and Natural Ingredients
Health-conscious buyers want traceable, minimally processed ingredients, and collagen peptides derived from natural sources fit that preference. Manufacturers are promoting their products as natural and ethically sourced, improving acceptance in the health and wellness market. Packaging is part of the story: in August 2024, Vital Proteins debuted an 80% paperboard canister for its best-selling collagen peptides, reducing plastic use by over 90% and offering curbside recyclability.
Segmentation Analysis
By source: The bovine segment earned USD 295.7 million in 2023 because of its availability, cost-effectiveness and high collagen content, making it the preferred choice across applications. It is projected to reach USD 450.4 million by 2031.
By form: Powder held 76.40% of the market in 2023, reflecting ease of use, versatility in formulations and a preference for mixable, customizable formats in both supplements and functional foods.
By extraction process: Enzymatic hydrolysis is projected to reach USD 684.5 million by 2031 owing to its ability to produce high-quality peptides with improved bioavailability and minimal degradation.
By application: Cosmeceuticals is the fastest-growing segment at a CAGR of 8.14%, supported by demand for anti-aging solutions and skin health improvement. Nutritional products, food and beverage, pharmaceuticals and pet nutrition complete the application view.
Regional Analysis
North America accounted for 34.09% of the market in 2023, valued at USD 239.4 million. A mature, competitive sports nutrition sector is adopting collagen peptides in protein powders, recovery blends and performance supplements, and U.S. supplement companies are innovating with flavored, mixable formats across online and retail channels. In June 2024, Glanbia Nutritionals and Jellice introduced Collameta, a patented high-potency collagen tripeptide initially offered in North America and positioned for joint health and muscle recovery.
Asia Pacific is poised to grow at a CAGR of 6.70%. Nutricosmetics have become a major trend, with consumers using supplements to improve skin appearance, elasticity and hydration. Beauty brands are offering collagen-enriched drinks, powders and tablets as part of daily routines, which is accelerating market growth.
Regulatory Landscape
In the U.S., collagen peptides are regulated as dietary supplements under the Dietary Supplement Health and Education Act of 1994; the FDA does not require pre-market approval but can act against misbranded or adulterated products. In Europe, EFSA oversight applies and products must comply with Regulation (EC) No 853/2004 on hygiene for food of animal origin. China’s NMPA regulates collagen peptides in medical and cosmetic applications, and the GB 31645-2018 standard specifies technical requirements. In Japan, the Consumer Affairs Agency oversees functional food labeling, and manufacturers may submit Foods with Function Claims notifications to support specific health claims.
Competitive Landscape
Companies are using product launches and portfolio expansion to meet demand for clean-label, flavored and function-specific collagen products, with targeted formulations for beauty, sports recovery and healthy aging. In May 2024, Rousselot, a Darling Ingredients brand, launched the Nextida platform of specific collagen peptide compositions; its first product, Nextida GC, demonstrated a significant reduction in post-meal glucose spikes.
Key companies profiled include GELITA AG, Darling Ingredients, Nitta Gelatin, Gelnex, Weishardt Group, Asahi Gelatine, Tessenderlo Group, Holista Colltech, Ewald-Gelatine, Geistlich Pharma, Juncà Gelatines, Italgelatine, Advanced BioMatrix, BioCell Technology and Athos Collagen.
Recent Developments
- November 2024: Nitta Gelatin introduced the DI-PEPTIDE product line to enhance collagen supplementation.
- November 2024: BioCell Technology launched BioCell Collagen ERP (Extra Refined Palatable) for non-pill formats such as gummies and chewables.
- May 2024: GELITA introduced new Bioactive Collagen Peptides solutions at Vitafoods Europe 2024, including PeptENDURE for sports nutrition, VERISOL for beauty, and FORTIBONE and FORTIGEL for healthy aging.
Strategic Insights and Opportunities
Kings Research sees several avenues for growth. Product format is one: while powder dominates, consumers are showing interest in ready-to-drink beverages, gummies, chewables and bars, and ingredient makers that offer peptides with neutral taste, good solubility and stability in these formats can win new business from food and supplement brands. Application-specific peptides are another avenue, since clinical evidence behind a particular benefit, whether skin hydration, joint comfort or muscle recovery, supports claims and justifies premium pricing.
Alternative sources represent a further opportunity. Marine and poultry collagen serve consumers with dietary preferences or regional restrictions, and fermentation-derived collagen opens the door to vegan positioning and tighter control over supply. As sourcing and sustainability pressures increase, suppliers that can document traceability, animal welfare standards and environmental performance will find it easier to meet the requirements of large retailers and global brands.
Pet nutrition and healthy aging are emerging end markets. Owners are increasingly adding joint and skin supplements to pet diets, and older consumers are looking for products that support mobility and bone health. Finally, regional strategy is important. North America’s demand is shaped by sports nutrition and personalization, Europe’s by strict regulatory expectations, and Asia Pacific’s by beauty-focused supplements that are part of daily routines. Suppliers that tailor formulations, claims and marketing to each region, while maintaining consistent quality, will be best placed to benefit from the market’s steady expansion.
Outlook
Kings Research expects growth to be shaped by product differentiation, traceable sourcing and sustainable packaging. Vegan and fermentation-derived collagen, tailored formulations for athletes, aging adults and beauty consumers, and palatable non-pill formats are likely to widen the addressable base. Asia Pacific’s nutricosmetics boom and North America’s sports nutrition depth are expected to remain complementary sources of demand through 2031.
About Kings Research
Kings Research is a market research and consulting firm that publishes syndicated reports and custom studies across healthcare, chemicals, materials, energy, technology and consumer sectors. Its reports combine quantitative market sizing with analysis of drivers, challenges, trends, regulation and competitive strategy to support business decisions.
Media Contact: Kings Research | 5348 Vegas Dr. Suite 305, Las Vegas, NV 89108 | [email protected]
